{"id":205917,"date":"2022-06-30T16:44:21","date_gmt":"2022-06-30T16:44:21","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=205917"},"modified":"2022-06-30T16:44:21","modified_gmt":"2022-06-30T16:44:21","slug":"pfizer-cere-aprobarea-oficiala-in-sua-a-paxlovid-tratamentul-oral-pentru-covid","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=205917","title":{"rendered":"Pfizer cere aprobarea oficial\u0103 \u00een SUA a Paxlovid, tratamentul oral pentru COVID"},"content":{"rendered":"<p>\nPfizer a precizat c\u0103 a depus la Administra\u0163ia american\u0103 pentru alimente \u015fi medicamente (FDA) o cerere de aprobare a Paxlovid pentru tratamentul COVID-19 la persoanele vaccinate \u015fi nevaccinate cu risc ridicat de evolu\u0163ie c\u0103tre o boal\u0103 sever\u0103, anun\u0163\u0103 Reuters.<\/p>\n<p>\nTratamentul cu dou\u0103 medicamente administrat timp de 5 zile \u00eencep\u00e2nd la scurt timp dup\u0103 debutul simptomelor COVID a redus cu 88% riscul de spitalizare sau deces la pacien\u0163ii adul\u0163i cu risc ridicat, neinterna\u0163i \u00een spital, \u00een cadrul studiului clinic efectuat de Pfizer, care nu a inclus persoane vaccinate.<\/p>\n<p>\nDatele unui studiu efectuat \u00een Israel la \u00eenceputul acestei luni au ar\u0103tat c\u0103 Paxlovid a redus ratele de spitalizare \u015fi de deces \u00een cazul COVID-19 la pacien\u0163ii vaccina\u0163i \u015fi nevaccina\u0163i cu v\u00e2rsta de peste 65 de ani, dar nu s-a constatat c\u0103 a prevenit \u00eemboln\u0103virile grave \u00een r\u00e2ndul adul\u0163ilor mai tineri.<\/p>\n<p>\nPeste 1,6 milioane de tratamente cu Paxlovid au fost administrate \u00een Statele Unite, potrivit datelor Departamentului pentru S\u0103n\u0103tate \u015fi Servicii Umane.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer a declarat joi c\u0103 cere aprobarea complet\u0103 \u00een SUA pentru tratamentul antiviral oral COVID-19 Paxlovid, disponibil acum \u00een baza unei autoriza\u0163ii de utilizare de urgen\u0163\u0103.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[50322,106],"class_list":["post-205917","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-paxlovid","tag-sua"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/205917","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=205917"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/205917\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=205917"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=205917"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=205917"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}